Statistics
Publications
16
Citations
761
H-Index
13
Active since
2008
Nobuyuki Katakami is an author at Foundation for Biomedical Research and Innovation specializing in medicine, oncology, and lung cancer.
Publications per year
2008–2018
16
16
Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib
Shiro Fujita, Katsuhiro Masago, Nobuyuki Katakami et al. · Journal of Thoracic Oncology · 2016 · 133 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 16